Home : December 2012 : December 03, 2012 News : Eporgen's Portfolio Company Genovax Sells GX301, its Clinical-Stage Therapeutic Vaccine for the Treatment of Various Types of Cancer, to Mediolanum Farmaceutici

Eporgen's Portfolio Company Genovax Sells GX301, its Clinical-Stage Therapeutic Vaccine for the Treatment of Various Types of Cancer, to Mediolanum Farmaceutici

December 03, 2012

MILAN and COLLERETTO GIACOSA, Italy, December 3, 2012 /PRNewswire/ -- Mediolanum Farmaceutici SpA, a privately owned company that leads the Mediolanum Farmaceutici Group of companies, and Genovax srl, a private company which belongs to the portfolio of Eporgen Venture and was originated...

http://www.prnewswire.com/news-releases/eporgens-portfolio-company-genovax-sells-gx301-its-clinical-stage-therapeutic-vaccine-for-the-treatment-of-various-types-of-cancer-to-mediolanum-farmaceutici-181783401.html
Other Stories